Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients

HonorHealth Research Institute

Status and phase

Completed

Phase 2

Conditions

Traumatic Brain Injury

Treatments

Drug: N-Acetyl cysteine

Study type

Interventional

Funder types

Other

Identifiers

NCT04291066

1445221

Details and patient eligibility

About

This study will evaluate the administration of N-Acetyl-cysteine in combination with multi-vitamins/minerals in geriatric population (>60 years of age) who have experienced a traumatic brain injury.

Full description

This study aims to determine the effect of supplemental N-acetyl cysteine and additional multi-vitamin/mineral therapy on somatic, cognitive, and emotional post-concussion symptoms as determined by the Rivermeade Post-concussion Questionnaire (RPQ) within 24 hours of admission, post injury day 7, and post injury day 30. The RPQ questionnaires will be given to patients older than 60 years, who have been evaluated by the HonorHealth John C. Lincoln Medical Center or Deer Valley Medical Center trauma service within 3 hours of sustaining a traumatic brain injury (TBI).

Enrollment

92 patients

Sex

All

Ages

60 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

60 years or older
present to emergency department within 3 hours of documented TBI

Exclusion criteria

patients without TBI
patients with a history of TBI greater than 3 hours prior to presentation
patients under the age of 60
currently enrolled in an ongoing research study
patients who at baseline prior to the TBI, cannot participate in cognitive function testing (aphasia, severe dementia, non verbal; prior to TBI)
Patients who are unable to tolerate PO medications within 3 hours of sustaining TBI.